Geautomatiseerde monsterbereiding om de nood aan analytische capaciteit voor biopharmaceutica en forensische toxicologie in te vullen.
IOF Proof of Concept: Realizing a chromatography-mass spectrometry expert facility for protein characterization in support of the biopharmaceutical sector
Symibs: een nieuwe klasse van designer intrabodies voor de ontwikkeling van antikanker behandeling met MYC en p53 als doelwit.
Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
POLYOXAZOLINE POLYMERS AND METHODS FOR THEIR PREPARATION, CONJUGATES OF THESE POLYMERS AND MEDICAL USES THEREOF